Rockefeller Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-10,715
| Closed | -$1.6M | – | 1629 |
|
|
2024
Q1 | $1.6M | Sell |
10,715
-358
| -3% | -$53.5K | ﹤0.01% | 1101 |
|
|
2023
Q4 | $2.12M | Sell |
11,073
-2,111
| -16% | -$404K | 0.01% | 891 |
|
|
2023
Q3 | $2.33M | Buy |
+13,184
| New | +$2.33M | 0.01% | 786 |
|
|
2023
Q2 | – | Sell |
-8,339
| Closed | -$1.67M | – | 1815 |
|
|
2023
Q1 | $1.67M | Sell |
8,339
-2,332
| -22% | -$466K | 0.01% | 878 |
|
|
2022
Q4 | $2.53M | Sell |
10,671
-1,010
| -9% | -$240K | 0.01% | 676 |
|
|
2022
Q3 | $2.34M | Sell |
11,681
-6,067
| -34% | -$1.21M | 0.01% | 717 |
|
|
2022
Q2 | $2.59M | Sell |
17,748
-356,216
| -95% | -$51.9M | 0.01% | 683 |
|
|
2022
Q1 | $61.1M | Sell |
373,964
-12,296
| -3% | -$2.01M | 0.29% | 80 |
|
|
2021
Q4 | $65.5M | Buy |
386,260
+68,160
| +21% | +$11.6M | 0.31% | 74 |
|
|
2021
Q3 | $60.1M | Sell |
318,100
-79,209
| -20% | -$15M | 0.32% | 71 |
|
|
2021
Q2 | $67.4M | Sell |
397,309
-3,251
| -0.8% | -$551K | 0.38% | 53 |
|
|
2021
Q1 | $56.6M | Buy |
400,560
+11,815
| +3% | +$1.67M | 0.38% | 55 |
|
|
2020
Q4 | $50.5M | Buy |
388,745
+3,949
| +1% | +$513K | 0.38% | 61 |
|
|
2020
Q3 | $56M | Sell |
384,796
-699
| -0.2% | -$102K | 0.52% | 34 |
|
|
2020
Q2 | $57.1M | Buy |
385,495
+23,440
| +6% | +$3.47M | 0.6% | 33 |
|
|
2020
Q1 | $39.4M | Sell |
362,055
-161,094
| -31% | -$17.5M | 0.52% | 39 |
|
|
2019
Q4 | $60.3M | Sell |
523,149
-56,727
| -10% | -$6.53M | 0.75% | 30 |
|
|
2019
Q3 | $46.6M | Buy |
579,876
+91,356
| +19% | +$7.35M | 0.63% | 38 |
|
|
2019
Q2 | $35.4M | Buy |
488,520
+863
| +0.2% | +$62.6K | 0.49% | 47 |
|
|
2019
Q1 | $45.6M | Buy |
487,657
+1,108
| +0.2% | +$104K | 0.65% | 37 |
|
|
2018
Q4 | $35.5M | Buy |
486,549
+160,083
| +49% | +$11.7M | 0.62% | 42 |
|
|
2018
Q3 | $28.6M | Buy |
326,466
+58,355
| +22% | +$5.11M | 0.43% | 60 |
|
|
2018
Q2 | $26.4M | Buy |
268,111
+20,357
| +8% | +$2M | 0.43% | 65 |
|
|
2018
Q1 | $29.5M | Buy |
+247,754
| New | +$29.5M | 0.49% | 58 |
|